fig1

Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours

Figure 1. Acquired HER2 alterations in patients with endocrine resistance. The location of HER2 alterations identified by sequencing metastatic biopsies is depicted along the length of the protein. Protein domains are indicated by colour coding. Evolutionary classification for alterations: red triangles, acquired alterations; blue triangles, alterations shared with primary tumour; grey triangles, indeterminate or unknown. Figure 1 and legend used from Nayar et al.[13].

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/